Navigation Links
Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
Date:9/21/2009

BETHESDA, Md., Sept. 21 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors. The interim data(1) were presented at the Multidisciplinary Congress of the European Cancer Organisation (ECCO) and 34th meeting of the European Society for Medical Oncology (ESMO) in Berlin, Germany. MT110 is designed to direct the patients' own T cells against cancer cells that express the epithelial cell adhesion molecule (EpCAM).

To date, 20 patients with late-stage lung or gastrointestinal cancers have been treated with MT110. The starting dose in this phase 1 dose escalation trial was 1 g per patient per day. Results from doses up to 12 g per patient per day were reported. MT110 is administered by continuous intravenous infusion for a minimum of four weeks with the option of additional treatment cycles until disease progression. No maximum tolerated dose has been reached and dose escalation is ongoing. MT110 is well tolerated with no grade 3 or 4 clinical events related to MT110 therapy observed so far. The most frequent adverse events related to MT110 treatment were mild pyrexia and fatigue. Laboratory analysis of all patients revealed an early clinically asymptomatic increase of liver enzymes that normalized after several days under continued treatment. Other laboratory abnormalities included transient lymphopenia. No cytokine release syndrome, pancreatitis or immune response to MT110 was observed. At the dose levels tested to date, disease stabilization was seen in 7 of 18 evaluable patients aft
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 Research and Markets has ... Pulp & Paper Industry Report 2014" report to ... Pulp & Paper Industry Report 2014 is a professional ... global enzyme for pulp & paper industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:8/27/2014)... Beach County, Florida (PRWEB) August 27, 2014 ... Company Inc. (SCI) is announcing the creation of ... priority is to take the SCI’s philosophy of ... the company’s research and development actions are based ... , This new Scientific Advisory Board provides a ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Remcom announces ... with new features for the biomedical industry. ... enhanced Biological Thermal Sensor, exclusive to the Bio-Pro version ... version of XFdtd, developed to calculate the biological effects ... has been added to all versions to expand engineers’ ...
(Date:8/26/2014)... 2014  NeuroSigma, Inc., a Los Angeles ... technologies, today announced that it has filed a registration ... Exchange Commission relating to a proposed initial public offering ... be offered and the price range for the proposed ... LLC will act as the book-running manager for the ...
Breaking Biology Technology:Global Enzyme for Pulp & Paper Industry Report 2014 2New Sancilio & Company, Inc. Scientific Board 2New Sancilio & Company, Inc. Scientific Board 3Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3
... VANCOUVER, May 11 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ... final survival data from a randomized Phase 2 ... docetaxel alone as first-line chemotherapy in patients with ... an oral presentation at the American Society of ...
... May 11 Dalton Pharma Services and ProCitius Research ... with contract chemistry services of ... maintain their discovery and development output in an era ... of "offshore" contract research organizations ...
... Barnard, has been awarded the International Union of Pure ... Computational Physics. , The award acknowledges Dr Barnard as ... the structures, shapes and crystal structures of materials at ... Melbourne Institute of Technology (RMIT) University in 2001 ...
Cached Biology Technology:OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 2OncoGenex Pharmaceuticals' Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting 3Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 2Dalton Pharma Services and ProCitius Announce a Strategic Alliance to Provide Contract Chemistry Services 3Big prize for 'small science' physicist 2
(Date:8/26/2014)... problems such as global warming and poverty the ... burden fall on our failure as consumers to ... study in the Journal of Consumer Research ... global problems from governments to consumers and ultimately ... convince politicians to encourage responsible consumption instead of ...
(Date:8/26/2014)... suggested an increased risk of autism among children ... actually reflect the known increased risk associated with ... advance online publication in Molecular Psychiatry , ... while a diagnosis of autism spectrum disorder ... prescribed antidepressants during pregnancy than in those with ...
(Date:8/26/2014)... A study from the University of Liverpool has recommended investing ... target physical inactivity and problems such as obesity in both ... papers published since 1990, the researchers found that access to ... could all motivate people to get out and take more ... of dog owners don,t take their dogs for a walk. ...
Breaking Biology News(10 mins):An inconvenient truth: Does responsible consumption benefit corporations more than society? 2Study calls into question link between prenatal antidepressant exposure and autism risk 2Study calls into question link between prenatal antidepressant exposure and autism risk 3Education and dog-friendly neighbourhoods could tackle obesity 2
... bacteria are bad. In fact, beneficial microbes could ... treat a variety of diseases in humans and animals ... disorders, according to a report released by the American ... "Theoretically, beneficial microorganisms could be used to treat a ...
... at Buffalo have received a $2.5 million five-year grant ... called "hibernating myocardium" that can cause disabling heart failure ... condition in which myocytes (cells in the heart's muscular ... receive reduced blood flow over an extended period of ...
... gene that could lead to breakthroughs in breast and ... called SLIRP, was discovered by a team at the ... Cancer Medicine, led by Professor Peter Leedman, in collaboration ... Medicine in Texas. , "When we baited our hook ...
Cached Biology News:Report focuses on the role good microbes play in future medicine 2Reversing 'hibernating' heart muscle focus of UB researchers 2Gene discovery opens door to tackling disease 2
...
... Black wall plates have low background ... crosstalk,• Not treated (or medium binding) ... and binds biomolecules through passive interactions,• ... immobilization of large molecules, such as ...
... is a compact benchtop and stackable ... controller with a large display screen ... speed. Air circulation inside to evenly ... can be easily calibrated from the ...
... MULTI-FUN Incubator is a compact ... uses a microprocessor controller with a ... temperature and agitation speed. Air circulation ... the incubator. Temperature can be easily ...
Biology Products: